Loading
QB
Quantum BioPharma Ltd. Stock: price and insider trades · Canada
Quantum BioPharma Ltd.: what insiders have been doing
Quantum BioPharma Ltd. is a listed company. Filings by its managers are published through SEDI. Over the twelve months to 18 October 2026, 5 filings were filed, from 5 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
For context, the typical company on the same exchange (median of 2,134 companies) published 12 filings over the same period, against 5 filings here.
Over the last twelve months, not one insider purchase of Quantum BioPharma Ltd. stock was filed. Filings reach the SEDI feed a median of 4 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
CA$4.10
Last declaration on 25 August 2026
Declarations6 total
17,000 shares@ CA$4.80100.0% of flowOptionsTSXSEDI:4768622
17,000 shares@ CA$4.80100.0% of flowOptionsTSXSEDI:4768176
29,500 shares@ CA$4.80100.0% of flowOptionsTSXSEDI:4768173
17,000 shares@ CA$4.80100.0% of flowOptionsTSXSEDI:4768171
400,000 shares@ CA$4.80100.0% of flowOptionsTSXSEDI:4768167
OptionsTSXSEDI:4470591
6 of 6 declarations
About Quantum BioPharma Ltd.
Quantum BioPharma Ltd. is a biopharmaceutical company focused on developing innovative treatments for serious diseases. It is listed on the Toronto Stock Exchange (XTSE).
